We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RIBOXX PHARMACEUTICALS Announce an Exclusive License Agreement

News   Feb 09, 2016

 
RIBOXX PHARMACEUTICALS Announce an Exclusive License Agreement
 
 
 

RELATED ARTICLES

Neutrons Paint Atomic Portrait of Protein Kinase A

News

Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis

READ MORE

AI Utilized to Predict Cancer's Migration to the Brain

News

A new precision medicine approach developed at the University of Michigan aims to predict cancer’s likelihood of migrating to the brain, and to aid in the search for new treatments

READ MORE

New Class of Drugs Could Treat Ovarian Cancer

News

A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE